Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2006-06-20

Clinical Trial Update: EpSSG (European Soft Tissue Sarcoma Study Group) Protocol for Non-Metastatic Rhabdomyosarcoma in Children [Phase 4]

View source ↗

Summary

This clinical trial update describes the EpSSG protocol for treating non-metastatic rhabdomyosarcoma in pediatric patients, currently in Phase 4.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Sheba Medical Center | Conditions: Rhabdomyosarcoma | Phase 4 | Status: UNKNOWN